Chemoinformaics analysis of BREVIFOLIN-CARBOXYLIC-ACID
Molecular Weight | 292.199 | nRot | 1 |
Heavy Atom Molecular Weight | 284.135 | nRig | 17 |
Exact Molecular Weight | 292.022 | nRing | 3 |
Solubility: LogS | -4.283 | nHRing | 1 |
Solubility: LogP | 1.043 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
No. of Oxygen atom | 8 | No. of Arom Bond | 11 |
nHA | 7 | APOL | 33.4603 |
nHD | 4 | BPOL | 12.3657 |
QED | 0.353 |
Synth | 3.73 |
Natural Product Likeliness | 1.076 |
NR-PPAR-gamma | 0.013 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.036 |
HIA | 0.026 |
CACO-2 | -5.481 |
MDCK | 0.000018 |
BBB | 0.007 |
PPB | 0.86397 |
VDSS | 0.736 |
FU | 0.156487 |
CYP1A2-inh | 0.096 |
CYP1A2-sub | 0.059 |
CYP2c19-inh | 0.022 |
CYP2c19-sub | 0.035 |
CYP2c9-inh | 0.167 |
CYP2c9-sub | 0.025 |
CYP2d6-inh | 0.001 |
CYP2d6-sub | 0.066 |
CYP3a4-inh | 0.009 |
CYP3a4-sub | 0.008 |
CL | 1.231 |
T12 | 0.804 |
hERG | 0.001 |
Ames | 0.229 |
ROA | 0.111 |
SkinSen | 0.562 |
Carcinogencity | 0.241 |
EI | 0.128 |
Respiratory | 0.396 |
NR-Aromatase | 0.005 |
Antiviral | Yes |
Prediction | 0.717316 |